Literature DB >> 17859590

II. Contribution to the Knowledge of Sarcoma.

W B Coley.   

Abstract

Entities:  

Year:  1891        PMID： 17859590      PMCID： PMC1428624          DOI： 10.1097/00000658-189112000-00015

Source DB:  PubMed          Journal:  Ann Surg        ISSN： 0003-4932            Impact factor:   12.969


× No keyword cloud information.
  194 in total

1.  The role of funding and policies on innovation in cancer drug development.

Authors:  P Kanavos; R Sullivan; G Lewison; W Schurer; S Eckhouse; Z Vlachopioti
Journal:  Ecancermedicalscience       Date:  2010-02-03

Review 2.  Therapeutic targeting of trained immunity.

Authors:  Willem J M Mulder; Jordi Ochando; Leo A B Joosten; Zahi A Fayad; Mihai G Netea
Journal:  Nat Rev Drug Discov       Date:  2019-07       Impact factor: 84.694

3.  PDL1 expression is a poor-prognosis factor in soft-tissue sarcomas.

Authors:  François Bertucci; Pascal Finetti; Delphine Perrot; Agnès Leroux; Françoise Collin; Axel Le Cesne; Jean-Michel Coindre; Jean-Yves Blay; Daniel Birnbaum; Emilie Mamessier
Journal:  Oncoimmunology       Date:  2017-02-08       Impact factor: 8.110

Review 4.  Vaccine and immune cell therapy in non-small cell lung cancer.

Authors:  Helena Oliveres; Christian Caglevic; Francesco Passiglia; Simona Taverna; Evelien Smits; Christian Rolfo
Journal:  J Thorac Dis       Date:  2018-05       Impact factor: 2.895

Review 5.  Tumour-targeting bacteria engineered to fight cancer.

Authors:  Shibin Zhou; Claudia Gravekamp; David Bermudes; Ke Liu
Journal:  Nat Rev Cancer       Date:  2018-12       Impact factor: 60.716

Review 6.  Immune escape mechanisms of intraocular tumors.

Authors:  Jerry Y Niederkorn
Journal:  Prog Retin Eye Res       Date:  2009-06-27       Impact factor: 21.198

Review 7.  Cardiotoxicity of Immune Checkpoint Inhibitors.

Authors:  Lili Zhang; Maeve Jones-O'Connor; Magid Awadalla; Daniel A Zlotoff; Paaladinesh Thavendiranathan; John D Groarke; Alexandra-Chloe Villani; Alexander R Lyon; Tomas G Neilan
Journal:  Curr Treat Options Cardiovasc Med       Date:  2019-06-08

Review 8.  No pain no gain? Adjuvant effects of alum and monophosphoryl lipid A in pertussis and HPV vaccines.

Authors:  Thomas C Mitchell; Carolyn R Casella
Journal:  Curr Opin Immunol       Date:  2017-07-17       Impact factor: 7.486

Review 9.  Bispecific T-Cell Redirection versus Chimeric Antigen Receptor (CAR)-T Cells as Approaches to Kill Cancer Cells.

Authors:  William R Strohl; Michael Naso
Journal:  Antibodies (Basel)       Date:  2019-07-03

10.  Reactive hyperplasia of paracortex and germinal centers of the regional lymph nodes in gastric carcinoma cases as a favorable prognostic indicator.

Authors:  Y Kodama; K Seojima; K Inokuchi
Journal:  Jpn J Surg       Date:  1976-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.